Benzylguanidines and other galegine analogues inducing weight loss in mice.
暂无分享,去创建一个
B. Furman | A. Harvey | M. Mooney | R. Waigh | G. Coxon | A. Kennedy | M. Arastoo | J. McTavish | Justice M Tettey
[1] M. Botta,et al. Novel substituted aminoalkylguanidines as potential antihyperglycemic and food intake-reducing agents. , 2008, Journal of medicinal chemistry.
[2] B. Furman,et al. Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice , 2008, British journal of pharmacology.
[3] A. Karapetyan,et al. Synthesis and antimonoamineoxidase activity of 4-methoxybenzylguanidine and its sulfate , 1998, Pharmaceutical Chemistry Journal.
[4] M. Kakei,et al. Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice. , 2005, Endocrine journal.
[5] E. Hesse,et al. Die Wirkung des Biguanids und seiner Derivate auf den Zuckerstoffwechsel , 1929, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[6] C. Day,et al. Metformin: its botanical background , 2004 .
[7] J. Rothbard,et al. Guanidinium rich peptide transporters and drug delivery. , 2003, Current protein & peptide science.
[8] L. Witters. The blooming of the French lilac. , 2001, The Journal of clinical investigation.
[9] T. Vidmar,et al. Synthesis and biological activity of aminoguanidine and diaminoguanidine analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid. , 2001, Journal of medicinal chemistry.
[10] C. Bouchard,et al. Gene-diet interactions in obesity. , 2000, The American journal of clinical nutrition.
[11] E. Vesell,et al. Studies on pyrazinoylguanidine: a novel antihypertensive, hypoglycemic and lipolytic drug intended for adjunctive use in hypertensive patients with type 2 diabetes mellitus. , 2000, Toxicology.
[12] A. Gray,et al. Novel Weight‐Reducing Activity of Galega officinalis in Mice , 1999, The Journal of pharmacy and pharmacology.
[13] C. Boyd,et al. Transporters for cationic amino acids in animal cells: discovery, structure, and function. , 1998, Physiological reviews.
[14] M. Villarroya,et al. Synthesis and pharmacology of alkanediguanidinium compounds that block the neuronal nicotinic acetylcholine receptor. , 1996, Bioorganic & medicinal chemistry.
[15] J. Luo,et al. Study of phenformin metabolism in rat liver microsomes by HPLC, CE and on-line HPLC-electrospray ionization mass spectrometry. , 1996, Biomedical chromatography : BMC.
[16] I. Leito,et al. Basicity of 3-aminopropionamidine derivatives in water and dimethyl sulphoxide. Implication for a pivotal step in the synthesis of distamycin A analogues , 1996 .
[17] Dominic P. Williams,et al. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. , 1995, The Journal of pharmacology and experimental therapeutics.
[18] P Watts,et al. The influence of medium composition on the maintenance of cytochrome P-450, glutathione content and urea synthesis: a comparison of rat and sheep primary hepatocyte cultures. , 1995, Journal of hepatology.
[19] A. Hinchliffe,et al. Relationships between the HOMO energies and pKa values in monocyclic and bicyclic azines , 1995 .
[20] J. Idle,et al. The genetic control of phenformin 4-hydroxylation. , 1985, Journal of medical genetics.
[21] E. Bosisio,et al. Defective Hydroxylation of Phenformin as a Determinant of Drug Toxicity , 1981, Diabetes.
[22] G. Kolata. The phenformin ban: is the drug an imminent hazard? , 1979, Science.
[23] J. C. Emmett,et al. CYANOGUANIDINE‐THIOUREA EQUIVALENCE IN THE DEVELOPMENT OF THE HISTAMINE H2‐RECEPTOR ANTAGONIST, CIMETIDINE , 1977 .
[24] G. Scholtysik,et al. Substituted phenylacetylguanidines: a new class of antihypertensive agents. , 1975, Arzneimittel-Forschung.
[25] D. Molho,et al. [Synthesis and pharmacologic selection of new antihypertensive agents]. , 1968, Therapie.
[26] M. Roginsky,et al. PHENFORMIN IN HUMAN OBESITY , 1968, Annals of the New York Academy of Sciences.
[27] A. Mckay,et al. Acylation of guanidines and guanylhydrazones , 1967 .
[28] T. Darby,et al. Sympathetic nervous system blocking agents. 3. Derivatives of benzylguanidine. , 1967, Journal of medicinal chemistry.
[29] V. Parrino,et al. Hypoglycemic Agents. IV.1—3 N1,N5-Alkyl- and Aralkylbiguanides , 1959 .
[30] V. Parrino,et al. Hypoglycemic Agents. I.1 Chemical Properties of β-Phenethylbiguanide.2 A New Hypoglycemic Agent3 , 1959 .
[31] G. Ungar,et al. Pharmacological Studies of a New Oral Hypoglycemic Drug , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[32] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[33] C. E. Braun,et al. The Preparation of Some Monoguanidines of Possible Physiological Significance1 , 1934 .